NCT02567799 2024-01-25
NSCLC
Humanetics Corporation
Phase 1/2 Completed
Clinical Trials
3 trialsNCT01628471 2015-09-23
MTD Determination, Safety and Efficacy of the Decitabine-Genistein Drug Combination in Advanced Solid Tumors and Non-Small Cell Lung Cancer
Uman Pharma
Phase 1/2 Completed
NCT01182246 2014-04-23
AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer
Axcentua Pharmaceuticals AB
Phase 1/2 Unknown